Aligarh : Dr Rifat Parvez Naghmi (Garland, Texas, USA) delineated the working of SGLT-2 inhibitors and how to prevent the kidneys from reabsorbing glucose back into the blood in an online lecture on ‘SGLT-2 Inhibitors’ and Dr Nilofar Syed (Assistant Professor, Southwestern University, Dallas, USA) discussed the guidance for the management of gout, indications for and optimal use of uratelowering therapy, treatment of gout flares, and lifestyle and other medication recommendations in the discourse on ‘Gout-Recent Guidelines’.
The two distinct talks delivered on different days were a part of online extension lectures of the Department of Medicine, Jawaharlal Nehru Medical College (JNMC), Aligarh Muslim University (AMU).
Dr Rifat emphasised: “SGLT2 inhibitors may be suitable for people with type 2 diabetes that have high blood glucose levels despite being on a medication regimen such as metformin and insulin, but are not recommended for prescribing to people with kidney diseases like nephropathy which prevents the drug from working sufficiently well”.
She further discussed the working and common side effects of SGLT2 inhibitors.
Dr Nilofar elaborated Diagnosis and Management of Gout.
She pointed out: “As patients with gout typically have hypertension and impaired renal function, examination of the renal and cardiovascular systems is essential. Baseline laboratory tests should include a complete blood cell count, urinalysis, and serum creatinine, blood urea nitrogen and serum uric acid measurements”.
Moderating both the lectures, Prof Anjum Mirza Chughtai (Chairman, Department of Medicine) said that these extension lectures increase the exposure of MD (Medicine) residents to the international norms of patient care and the nuances of medical research globally.
He discussed knowledge and experience in the field and shared ideas for eye-opening new research.